Promethazine (Phenergan INJ (25mg)) is an antihistamine and antiemetic, prescribed for allergic conditions, prevention of motion sickness, and to control nausea and vomiting during and after ...
Promethazine HCl 25mg/mL, 50mg/mL; sol for IM or IV inj; contains sulfites. Sulfite sensitivity. CNS depression. Impaired respiratory function (eg, COPD, sleep apnea). Narrow-angle glaucoma. GI or GU ...
The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, ...
Jan. 4, 2006 — The US Food and Drug Administration (FDA) approved in November 2005 first-time generic formulations of promethazine HCl 12.5-, 25-, and 50-mg tablets for approved indications in ...
An old drug with a wide range of uses now has a new FDA alert that could spare patients from some severe reactions. The FDA communication covers promethazine hydrochloride, a medicine approved for ...
Jan. 26, 2005 — The U.S. Food and Drug Administration (FDA) approved in November 2004 revisions to safety labeling to advise healthcare professionals of the following changes: valdecoxib use is ...
Promethazine (Phenergan INJ) is an antihistamine and antiemetic, prescribed for allergic conditions, prevention of motion sickness, and to control nausea and vomiting during and after surgery.It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback